Meta-analysis of Left Atrial Appendage Closure Versus Anticoagulation in Patients With Atrial Fibrillation

[...]a growing number of patients have a contraindication or are deemed inappropriate for long-term OAC therapy1 and therefore an alternative mechanical strategy to prevent left atrial appendage (LAA) thrombus migration has emerged to treat this population. Compared with OAC, LAAC was associated wit...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of cardiology 2020-10, Vol.132, p.181-182
Main Authors: Kheiri, Babikir, Kumar, Kris, Simpson, Timothy F., Osman, Mohammed, Dalouk, Khidir, Beitinjaneh, Bassel, Golwala, Harsh, Henrikson, Charles A.
Format: Article
Language:English
Subjects:
Antagonists
Anticoagulants
Bleeding
Cardiac arrhythmia
Embolism
Embolisms
Fibrillation
Ischemia
Meta-analysis
Mortality
Patients
Stroke
Thromboembolism
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c422t-8d0b427ff8d2056d417c6388afd5e2187805f255176c700885d59d24b1ba50453
cites cdi_FETCH-LOGICAL-c422t-8d0b427ff8d2056d417c6388afd5e2187805f255176c700885d59d24b1ba50453
container_end_page 182
container_issue
container_start_page 181
container_title The American journal of cardiology
container_volume 132
creator Kheiri, Babikir
Kumar, Kris
Simpson, Timothy F.
Osman, Mohammed
Dalouk, Khidir
Beitinjaneh, Bassel
Golwala, Harsh
Henrikson, Charles A.
description [...]a growing number of patients have a contraindication or are deemed inappropriate for long-term OAC therapy1 and therefore an alternative mechanical strategy to prevent left atrial appendage (LAA) thrombus migration has emerged to treat this population. Compared with OAC, LAAC was associated with a statistically significant reduction of all-cause death (incident-rate-ratio = 0.74, 95% CI 0.56 to 0.99, p = 0.02; HR 0.73, 95% CI 0.56 to 0.97, p = 0.03; absolute-risk-difference = 2.6%) and cardiovascular death (HR 0.63, 95% CI 0.42 to 0.94, p = 0.02). [...]in selected patients with nonvalvular AF, LAAC is associated with lower all-cause and cardiovascular death, and nonprocedural bleeding without increased ischemic events.
doi_str_mv 10.1016/j.amjcard.2020.07.022
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2432856565</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002914920307566</els_id><sourcerecordid>2432856565</sourcerecordid><originalsourceid>FETCH-LOGICAL-c422t-8d0b427ff8d2056d417c6388afd5e2187805f255176c700885d59d24b1ba50453</originalsourceid><addsrcrecordid>eNqFkU1rGzEQhkVJoY7bn1AQ5JLLbkbyald7CsbEbcClPfTjKGRp1tWyXjmSNuB_Hxk7l1zCHGYGnnmZmZeQrwxKBqy-60u9740OtuTAoYSmBM4_kBmTTVuwli2uyAwAeNGyqv1ErmPsc8uYqGek_4FJF3rUwzG6SH1HN9glukzB6YEuDwccrd4hXQ0-TgHpXwxxinQ5Jme83k2DTs6P1I30V65wTJH-c-n_q8DabYMbztBn8rHTQ8Qvlzwnf9YPv1ffi83Pb4-r5aYwFeepkBa2FW-6TloOorYVa0y9kFJ3ViDPN0kQHReCNbVpAKQUVrSWV1u21QIqsZiT27PuIfinCWNSexcN5i1G9FNUvFpwKeocGb15g_Z-CvkZJ6rK2i20dabEmTLBxxiwU4fg9jocFQN1ckD16uKAOjmgoFHZgTx3f57DfO2zw6CiyS8yaF1Ak5T17h2FF6B7kLI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2440889096</pqid></control><display><type>article</type><title>Meta-analysis of Left Atrial Appendage Closure Versus Anticoagulation in Patients With Atrial Fibrillation</title><source>ScienceDirect Journals</source><creator>Kheiri, Babikir ; Kumar, Kris ; Simpson, Timothy F. ; Osman, Mohammed ; Dalouk, Khidir ; Beitinjaneh, Bassel ; Golwala, Harsh ; Henrikson, Charles A.</creator><creatorcontrib>Kheiri, Babikir ; Kumar, Kris ; Simpson, Timothy F. ; Osman, Mohammed ; Dalouk, Khidir ; Beitinjaneh, Bassel ; Golwala, Harsh ; Henrikson, Charles A.</creatorcontrib><description>[...]a growing number of patients have a contraindication or are deemed inappropriate for long-term OAC therapy1 and therefore an alternative mechanical strategy to prevent left atrial appendage (LAA) thrombus migration has emerged to treat this population. Compared with OAC, LAAC was associated with a statistically significant reduction of all-cause death (incident-rate-ratio = 0.74, 95% CI 0.56 to 0.99, p = 0.02; HR 0.73, 95% CI 0.56 to 0.97, p = 0.03; absolute-risk-difference = 2.6%) and cardiovascular death (HR 0.63, 95% CI 0.42 to 0.94, p = 0.02). [...]in selected patients with nonvalvular AF, LAAC is associated with lower all-cause and cardiovascular death, and nonprocedural bleeding without increased ischemic events.</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/j.amjcard.2020.07.022</identifier><language>eng</language><publisher>New York: Elsevier Inc</publisher><subject>Antagonists ; Anticoagulants ; Bleeding ; Cardiac arrhythmia ; Embolism ; Embolisms ; Fibrillation ; Ischemia ; Meta-analysis ; Mortality ; Patients ; Stroke ; Thromboembolism</subject><ispartof>The American journal of cardiology, 2020-10, Vol.132, p.181-182</ispartof><rights>2020 Elsevier Inc.</rights><rights>2020. Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c422t-8d0b427ff8d2056d417c6388afd5e2187805f255176c700885d59d24b1ba50453</citedby><cites>FETCH-LOGICAL-c422t-8d0b427ff8d2056d417c6388afd5e2187805f255176c700885d59d24b1ba50453</cites><orcidid>0000-0003-1747-2859</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Kheiri, Babikir</creatorcontrib><creatorcontrib>Kumar, Kris</creatorcontrib><creatorcontrib>Simpson, Timothy F.</creatorcontrib><creatorcontrib>Osman, Mohammed</creatorcontrib><creatorcontrib>Dalouk, Khidir</creatorcontrib><creatorcontrib>Beitinjaneh, Bassel</creatorcontrib><creatorcontrib>Golwala, Harsh</creatorcontrib><creatorcontrib>Henrikson, Charles A.</creatorcontrib><title>Meta-analysis of Left Atrial Appendage Closure Versus Anticoagulation in Patients With Atrial Fibrillation</title><title>The American journal of cardiology</title><description>[...]a growing number of patients have a contraindication or are deemed inappropriate for long-term OAC therapy1 and therefore an alternative mechanical strategy to prevent left atrial appendage (LAA) thrombus migration has emerged to treat this population. Compared with OAC, LAAC was associated with a statistically significant reduction of all-cause death (incident-rate-ratio = 0.74, 95% CI 0.56 to 0.99, p = 0.02; HR 0.73, 95% CI 0.56 to 0.97, p = 0.03; absolute-risk-difference = 2.6%) and cardiovascular death (HR 0.63, 95% CI 0.42 to 0.94, p = 0.02). [...]in selected patients with nonvalvular AF, LAAC is associated with lower all-cause and cardiovascular death, and nonprocedural bleeding without increased ischemic events.</description><subject>Antagonists</subject><subject>Anticoagulants</subject><subject>Bleeding</subject><subject>Cardiac arrhythmia</subject><subject>Embolism</subject><subject>Embolisms</subject><subject>Fibrillation</subject><subject>Ischemia</subject><subject>Meta-analysis</subject><subject>Mortality</subject><subject>Patients</subject><subject>Stroke</subject><subject>Thromboembolism</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNqFkU1rGzEQhkVJoY7bn1AQ5JLLbkbyald7CsbEbcClPfTjKGRp1tWyXjmSNuB_Hxk7l1zCHGYGnnmZmZeQrwxKBqy-60u9740OtuTAoYSmBM4_kBmTTVuwli2uyAwAeNGyqv1ErmPsc8uYqGek_4FJF3rUwzG6SH1HN9glukzB6YEuDwccrd4hXQ0-TgHpXwxxinQ5Jme83k2DTs6P1I30V65wTJH-c-n_q8DabYMbztBn8rHTQ8Qvlzwnf9YPv1ffi83Pb4-r5aYwFeepkBa2FW-6TloOorYVa0y9kFJ3ViDPN0kQHReCNbVpAKQUVrSWV1u21QIqsZiT27PuIfinCWNSexcN5i1G9FNUvFpwKeocGb15g_Z-CvkZJ6rK2i20dabEmTLBxxiwU4fg9jocFQN1ckD16uKAOjmgoFHZgTx3f57DfO2zw6CiyS8yaF1Ak5T17h2FF6B7kLI</recordid><startdate>20201001</startdate><enddate>20201001</enddate><creator>Kheiri, Babikir</creator><creator>Kumar, Kris</creator><creator>Simpson, Timothy F.</creator><creator>Osman, Mohammed</creator><creator>Dalouk, Khidir</creator><creator>Beitinjaneh, Bassel</creator><creator>Golwala, Harsh</creator><creator>Henrikson, Charles A.</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7Z</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1747-2859</orcidid></search><sort><creationdate>20201001</creationdate><title>Meta-analysis of Left Atrial Appendage Closure Versus Anticoagulation in Patients With Atrial Fibrillation</title><author>Kheiri, Babikir ; Kumar, Kris ; Simpson, Timothy F. ; Osman, Mohammed ; Dalouk, Khidir ; Beitinjaneh, Bassel ; Golwala, Harsh ; Henrikson, Charles A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c422t-8d0b427ff8d2056d417c6388afd5e2187805f255176c700885d59d24b1ba50453</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Antagonists</topic><topic>Anticoagulants</topic><topic>Bleeding</topic><topic>Cardiac arrhythmia</topic><topic>Embolism</topic><topic>Embolisms</topic><topic>Fibrillation</topic><topic>Ischemia</topic><topic>Meta-analysis</topic><topic>Mortality</topic><topic>Patients</topic><topic>Stroke</topic><topic>Thromboembolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kheiri, Babikir</creatorcontrib><creatorcontrib>Kumar, Kris</creatorcontrib><creatorcontrib>Simpson, Timothy F.</creatorcontrib><creatorcontrib>Osman, Mohammed</creatorcontrib><creatorcontrib>Dalouk, Khidir</creatorcontrib><creatorcontrib>Beitinjaneh, Bassel</creatorcontrib><creatorcontrib>Golwala, Harsh</creatorcontrib><creatorcontrib>Henrikson, Charles A.</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Physical Education Index</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest research library</collection><collection>Biochemistry Abstracts 1</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kheiri, Babikir</au><au>Kumar, Kris</au><au>Simpson, Timothy F.</au><au>Osman, Mohammed</au><au>Dalouk, Khidir</au><au>Beitinjaneh, Bassel</au><au>Golwala, Harsh</au><au>Henrikson, Charles A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Meta-analysis of Left Atrial Appendage Closure Versus Anticoagulation in Patients With Atrial Fibrillation</atitle><jtitle>The American journal of cardiology</jtitle><date>2020-10-01</date><risdate>2020</risdate><volume>132</volume><spage>181</spage><epage>182</epage><pages>181-182</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><abstract>[...]a growing number of patients have a contraindication or are deemed inappropriate for long-term OAC therapy1 and therefore an alternative mechanical strategy to prevent left atrial appendage (LAA) thrombus migration has emerged to treat this population. Compared with OAC, LAAC was associated with a statistically significant reduction of all-cause death (incident-rate-ratio = 0.74, 95% CI 0.56 to 0.99, p = 0.02; HR 0.73, 95% CI 0.56 to 0.97, p = 0.03; absolute-risk-difference = 2.6%) and cardiovascular death (HR 0.63, 95% CI 0.42 to 0.94, p = 0.02). [...]in selected patients with nonvalvular AF, LAAC is associated with lower all-cause and cardiovascular death, and nonprocedural bleeding without increased ischemic events.</abstract><cop>New York</cop><pub>Elsevier Inc</pub><doi>10.1016/j.amjcard.2020.07.022</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0003-1747-2859</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0002-9149
ispartof The American journal of cardiology, 2020-10, Vol.132, p.181-182
issn 0002-9149
1879-1913
language eng
recordid cdi_proquest_miscellaneous_2432856565
source ScienceDirect Journals
subjects Antagonists
Anticoagulants
Bleeding
Cardiac arrhythmia
Embolism
Embolisms
Fibrillation
Ischemia
Meta-analysis
Mortality
Patients
Stroke
Thromboembolism
title Meta-analysis of Left Atrial Appendage Closure Versus Anticoagulation in Patients With Atrial Fibrillation
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T09%3A57%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Meta-analysis%20of%20Left%20Atrial%20Appendage%20Closure%20Versus%20Anticoagulation%20in%20Patients%20With%20Atrial%20Fibrillation&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=Kheiri,%20Babikir&rft.date=2020-10-01&rft.volume=132&rft.spage=181&rft.epage=182&rft.pages=181-182&rft.issn=0002-9149&rft.eissn=1879-1913&rft_id=info:doi/10.1016/j.amjcard.2020.07.022&rft_dat=%3Cproquest_cross%3E2432856565%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c422t-8d0b427ff8d2056d417c6388afd5e2187805f255176c700885d59d24b1ba50453%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2440889096&rft_id=info:pmid/&rfr_iscdi=true